End-stage renal disease
Conditions
Interventions
Experimental group:The intervention group received a precise volume management strategy. A specialized management team assessed the patients' dry weight using a bioelectrical impedance analysis device
Control Group:Dry weight was assessed and ultrafiltration volume was determined using clinical evaluation methods, without the administration of diuretics.
Sponsors
Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Age 18–80 years; 2. Newly started on hemodialysis, expected to undergo hemodialysis at our hospital for >12 months; 3. Urine output >200ml/day; 4. No metal joint prostheses, cardiac stents, pacemakers, or other metal objects in the body that may interfere with bioelectrical impedance measurement; 5. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Complicated severe infections, heart failure; 2. Malignant tumors, active pulmonary tuberculosis, active lupus, severe liver disease, trauma, mental disorders; 3. Acute renal failure or patients switching from peritoneal dialysis to hemodialysis; 4. Long-term use of nephrotoxic drugs, amputation, pregnancy; 5. Patients taking other diuretics; 6. Patients with hypokalemia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urea clearance rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Cardiovascular Disease; | — |
Countries
China
Contacts
Public ContactHuang Chunxiang
Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University
Outcome results
None listed